BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29982329)

  • 1. Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient.
    Larsson S; Wenger A; Dósa S; Sabel M; Kling T; Carén H
    Carcinogenesis; 2018 Oct; 39(10):1304-1309. PubMed ID: 29982329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
    Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ
    BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
    Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
    Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
    J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.
    Zorniak M; Clark PA; Leeper HE; Tipping MD; Francis DM; Kozak KR; Salamat MS; Kuo JS
    Clin Cancer Res; 2012 Jul; 18(13):3628-36. PubMed ID: 22589395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture.
    Marques-Torrejon MA; Gangoso E; Pollard SM
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29196443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
    Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
    EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Glioma Models: From Patients to Dish to Animals.
    da Hora CC; Schweiger MW; Wurdinger T; Tannous BA
    Cells; 2019 Sep; 8(10):. PubMed ID: 31574953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
    McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
    Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
    Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
    Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells.
    Nakod PS; Kim Y; Rao SS
    Cancer Lett; 2018 Aug; 429():41-53. PubMed ID: 29746930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
    Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
    Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
    Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
    PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.